Patient recruitment inefficiencies delay up to 85% of clinical trials, costing sponsors $600K–$8M per day. With less than 5% of eligible patients enrolling, recruitment remains a major challenge. Explore key insights and data-driven strategies to improve retention and accelerate trial success.
Pharma and medtech invest billions in clinical research, yet inefficiencies in site and investigator selection delay trials and inflate costs. Discover how AI-driven insights and real-time data can optimize trial site feasibility, improve patient recruitment, and accelerate time to market.
Pharma and medtech invested $238 billion in R&D in 2022—but inefficiencies in early-stage collaboration with HCPs and KOLs are driving costs up and slowing innovation. Discover how Meplis helps optimize R&D collaboration to maximize ROI.